Skip to main content

Advertisement

Log in

hTERT mRNA Partially Regulates Telomerase Activity in Gastric Adenocarcinoma and Adjacent Normal Gastric Mucosa

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The extent to which human telomerase reverse transcriptase (hTERT) mRNA and its splice variants control telomerase activity in human cancers is controversial. Telomerase and hTERT mRNA were assessed quantitatively in paired samples of gastric adenocarcinoma and adjacent normal tissue. Splice variants within the hTERT reverse transcriptase domain (α, β, α β) were detected by RT-PCR. In gastric adenocarcinoma, compared to normal tissue, median telomerase activity increased significantly (from 0 total product generated [tpg; 95% confidence interval CI, 0–2.3] to 16.1 tpg [95% CI, 3.7–97]; P = 0.008) and median hTERT mRNA levels also increased (from 2.21 [95% CI, 1.40–4.62] to 7.08 [95% CI, 3.26–10.8]; P = 0.0054). hTERT mRNA and telomerase activity correlated in normal gastric mucosa (r = 0.819, P = 0.0002). α, β, and αβ deletions were similar in both groups. We conclude that hTERT mRNA partially regulates telomerase activity in normal gastric mucosa and gastric adenocarcinoma. In contrast, hTERT mRNA splicing is not involved in the regulation of enzyme activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. World Health Organization: The World Health Report 2000: Health Systems, Improving Performance. Geneva, WHO, 2000

  2. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1132, 1991

    PubMed  Google Scholar 

  3. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33(5):787–791, 1997

    PubMed  Google Scholar 

  4. Usselmann B, Newbold M, Morris AG, Nwokolo CU: Telomerase activity and patient survival after surgery for gastric and esophageal cancer. Eur J Gastroenterol Hepatol 13(8):903–908, 2001

    PubMed  Google Scholar 

  5. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–352, 1998

    PubMed  Google Scholar 

  6. Nakayama JI, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T, Ishikawa F: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18:65–68, 1998

    PubMed  Google Scholar 

  7. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA: hEST2, putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785–795, 1997

    PubMed  Google Scholar 

  8. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR: Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58:4168–4172, 1998

    PubMed  Google Scholar 

  9. Brenner CA, Wolny YM, Adler RR, Cohen J: Alternative splicing of the telomerase catalytic subunit in human oocytes and embryos. Mol Hum Reprod 5(9):845–850, 1999

    PubMed  Google Scholar 

  10. Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel, RR: The hTERTα splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2:426–432, 2000

    PubMed  Google Scholar 

  11. Yi X, White DM, Aisner DL, Baur JA, Wright WE, Shay JW: An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2(5):433–440, 2000

    PubMed  Google Scholar 

  12. Wang J, Xie LY, Allan S, Beach D, Hannon GJ: Myc activates telomerase. Genes Dev 12:1769–1774, 1998

    PubMed  Google Scholar 

  13. Kyo S, Takakura M, Kanaya T, Wang Z, Fujimoto K, Nishio Y, Orimo A, Inoue M: Estrogen activates telomerase. Cancer Res 59:5917–5921, 1999

    PubMed  Google Scholar 

  14. Wang Z, Kyo S, Takakura M, Tanaka M, Yatabe N, Maida Y, Fujiwara M, Hayakawa J, Ohmichi M, Koike K, Inoue M: Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway. Cancer Res 60:5376–5381, 2000

    PubMed  Google Scholar 

  15. Oh S, Song Y, Yim J, Kim T: The Wilms’ tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J Biol Chem 274:37473–37478, 1999

    PubMed  Google Scholar 

  16. Oh S, Song YH, Yim J, Kim TK: Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene 19:1485–1490, 2000

    PubMed  Google Scholar 

  17. Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M: Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res 6:1239–1247, 2000

    PubMed  Google Scholar 

  18. Kim NW, Wu F: Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 25(13):2595–2597, 1997

    PubMed  Google Scholar 

  19. Sachs L: Applied Statistics: A Handbook of Techniques. New York, Springer Verlag, 1982, pp 317–318

    Google Scholar 

  20. Nakamura Y, Tahara E, Tahara H, Yasui W, Tahara E, Ide T: Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues. Mol Carcinog 26:312–320, 1999

    PubMed  Google Scholar 

  21. Yasui W, Tahara H, Tahara E, Fujimoto J, Nakayama JI, Ishikawa F, Ide T, Tahara, E: Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas. Jpn J Cancer Res 89:1099–1103, 1998

    Google Scholar 

  22. Jong HS, Park YI, Kim S, Sohn JH, Kang SH, Song SH, Bang YJ, Kim NK: Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer 86:559–565, 1999

    PubMed  Google Scholar 

  23. Suzuki K, Kashimura H, Ohkawa J, Itabashi M, Watanabe T, Sawahata T, Nakahara A, Muto H, Tanaka N: Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions. J Gastroenterol Hepatol 15:744–751, 2000

    PubMed  Google Scholar 

  24. Li H, Zhao L, Yang Z, Funder JW, Liu JP: Telomerase is controlled by protein kinase Cα in human breast cancer cells. J Biol Chem 273(50):33436–33442, 1998

    PubMed  Google Scholar 

  25. Kharbanda S, Kumar V, Dhar S, Pandey P, Chen C, Majumder P, Yuan ZM, Whang Y, Strauss W, Pandita TK, Weaver D, Kufe D: Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase. Curr Biol 10:568–575, 2000

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. U. Nwokolo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barclay, J.Y., Morris, A.G. & Nwokolo, C.U. hTERT mRNA Partially Regulates Telomerase Activity in Gastric Adenocarcinoma and Adjacent Normal Gastric Mucosa. Dig Dis Sci 50, 1299–1303 (2005). https://doi.org/10.1007/s10620-005-2776-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-2776-5

Key Words

Navigation